Delivery Order SPE2DB22D1017-SPE2DB25FG9LU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,020.62 to AmerisourceBergen Drug Corp for Venlafaxine HCL 75 mg tablets (100 count) on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is also AmerisourceBergen's corporate headquarters. This delivery order represents a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,010,710 units of the pharmaceutical drug Venlafaxine HCL ER 75 mg capsules. The $1,864.74 contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA through December 31, 2025,...
- This is a $56,290.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 1,000 units of the prescription medication Venlafaxine HCL ER 75 mg capsules. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,149.48 contract is for the delivery of 4,564,113,042 units of Venlafaxine HCl ER 150 mg capsules. The award has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Venlafaxine HCL ER 75 mg capsules, a generic antidepressant medication, with a ceiling value of $1,943.13 and a period of performance through May 2, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VENLAFAXINE HCL ER 75 MG CAP 90S. The contract is a Delivery Order with a Firm Fixed Price of $1,169.59 and an Ultimate Completion Date of October 31, 2023. The contract is not designated as a Set-Aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This delivery order, awarded September 5, 2025, represents a $1,706.60 firm fixed-price procurement of Venlafaxine HCL ER 75 mg capsules (90-count) supplied by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA). The contract is non-set-aside and carries an ultimate completion date of September 8, 2025, with performance at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a $344.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561739496 VENLAFAXINE HCL ER 37.5 MG CAP 90S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance from August 8-9, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the specified...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.50 firm-fixed-price delivery order is for the supply of venlafaxine hydrochloride extended-release 75 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal contract award by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 1,000 units of VENLAFAXINE HCL ER 75 MG capsules. The contract has a ceiling value of $29,479.85 and is a firm fixed-price delivery order with a performance period ending on May 31, 2024. The contract was awarded on May 30, 2022 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9LUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,424.53 to AmerisourceBergen Drug Corp for 500 capsules of Venlafaxine HCL ER 75 mg on August 11, 2025, with completion scheduled for August 12, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through the government's open procurement process. The pharmaceutical product will be performed at the contractor's location in Conshohocken, Pennsylvania. This award is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The parent IDC serves as a flexible vehicle enabling the contractor to fulfill pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/11/25 |